到2030年规上医药工业企业将基本实现数智化转型全覆盖

Core Viewpoint - The "Implementation Plan for the Digital and Intelligent Transformation of the Pharmaceutical Industry (2025-2030)" aims for comprehensive digital transformation of large-scale pharmaceutical enterprises by 2030, enhancing competitiveness and ensuring drug quality and supply security [1][2] Group 1: Development Goals - By 2027, significant progress in digital transformation is expected, including breakthroughs in key technologies and the development of over 100 high-performance products in smart pharmaceutical equipment and software [1] - More than 100 intelligent pharmaceutical factories and over 10 innovation platforms for pharmaceutical models and technology applications are to be established by 2027 [1] - By 2030, large-scale pharmaceutical enterprises are expected to achieve full coverage of digital transformation, with enhanced innovation capabilities and a more complete data system across the pharmaceutical industry [1] Group 2: Specific Actions - The plan outlines 14 specific tasks focusing on four main areas: empowering actions through digital technology, promoting digital transformation, building a digital service system, and enhancing digital supervision [2] - It encourages collaboration among pharmaceutical companies, medical institutions, and research institutes to build a pharmaceutical big data platform for high-quality data collection across various fields [2] - The establishment of high-performance cloud computing platforms, blockchain, data centers, and other information infrastructure is encouraged to support the digital transformation of pharmaceutical enterprises [2] Group 3: Policy Support - The Ministry of Industry and Information Technology will strengthen policy coordination and increase support for the digital transformation of the pharmaceutical industry through national science and technology projects [2] - Local governments are encouraged to enhance resource support and promote cross-regional cooperation among pharmaceutical enterprises and their supply chains [2] - The plan also aims to align domestic and international regulations, standards, and technical exchanges in the field of pharmaceutical digitalization [2]